MedPath

Autobahn Therapeutics, Inc.

Autobahn Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://www.autobahntx.com

Clinical Trials

5

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 1
1 (33.3%)

Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults

Phase 2
Recruiting
Conditions
Bipolar Disorder Depression
Interventions
First Posted Date
2025-03-11
Last Posted Date
2025-06-22
Lead Sponsor
Autobahn Therapeutics, Inc.
Target Recruit Count
35
Registration Number
NCT06869187
Locations
🇺🇸

Autobahn Site #201, Cromwell, Connecticut, United States

🇺🇸

Autobahn Site #208, Cherry Hill, New Jersey, United States

🇺🇸

Autobahn Site #205, Marlton, New Jersey, United States

and more 3 locations

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Phase 2
Recruiting
Conditions
Major Depressive Disorder
Interventions
Other: Placebo
First Posted Date
2024-10-09
Last Posted Date
2025-06-20
Lead Sponsor
Autobahn Therapeutics, Inc.
Target Recruit Count
230
Registration Number
NCT06633016
Locations
🇺🇸

Autobahn Site #131, Birmingham, Alabama, United States

🇺🇸

Autobahn Site #132, Chandler, Arizona, United States

🇺🇸

Autobahn Site #116, Phoenix, Arizona, United States

and more 39 locations

SAD/MAD of ABX-002-1902 Investigating the Safety, Pharmacokinetics/Pharmacodynamics of in Healthy Subjects

Phase 1
Completed
Conditions
MDD
Interventions
Drug: Placebo
First Posted Date
2022-09-06
Last Posted Date
2023-09-15
Lead Sponsor
Autobahn Therapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT05528315
Locations
🇦🇺

Nucleus Network, Melbourne, Victoria, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.